The survival rate of mice treated with irradiated CD47−/− 3BD9 cells improved marginally – 10-day increase in survival (Fig. 3b), and there was a significant delay in tumor growth – 1.5-fold reduced tumor sizes (Fig. 3c), similar to the trend observed in the prophylactic vaccination regime. The gene discussed is CD47; the disease is neoplasm.